Biotechnology Industry Organization announced the election of Rachel King, President and CEO, GlycoMimetics, Inc, as the new Chair of its Board of Directors for the 2013-2014 term, and the election of David Pyott, Chairman, President, & CEO, Allergan Inc., as its new Board Secretary. Mrs. King formerly served as Vice Chair of the Health Section Governing Board, as well as on the Executive Committee, and is a former Chair of the Emerging Companies Section Governing Board. Members of the Executive Committee of BIO's Board of Directors for the 2013-2014 term are: Rick Eno, President & CEO, Metabolix -- IES Governing Board Vice Chair; Neal Gutterson, President & CEO, Mendel Biotechnology -- FAS Governing Board Vice Chair; Geno Germano, President and General Manager of Speciality Care and Oncology, Pfizer -- At-Large; Perry Karsen, Chief Operations Officer, Celgene -- At-Large; and Jonathan Peacock, Executive Vice President & CEO, Amgen -- At-Large. The newly-elected Board Members from these Sections are: Health Section Governing Board -- Adrian Adams, President and CEO, Auxilium Pharmaceuticals; Stuart Arbuckle, Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals; Alex M. Azar, III, President, Lilly USA, Eli Lilly & Co.; Roch Doliveux, Chairman of the Executive Committee & CEO, UCB; William Fitzsimmons, Divisional Executive Vice President for Global Regulatory Affairs and Global Clinical and Research Quality Assurance, Astellas Pharma US; Paul Hudson, Executive Vice President, North America, AstraZeneca, PLC; Frank Verwiel, President & CEO, Aptalis Pharma Emerging Companies Section Governing Board; Andrew Hindman, President & CEO, Tobira Therapeutics; and Martin Babler, Chief Executive Officer, Principia Bio.

Biotechnology Industry Organization Presents at 2013 BIO International Convention, Apr-23-2013 12:00 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States. Speakers: Jim Greenwood, President and CEO.

Biotechnology Industry Organization Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 through Mar-13-2013. Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain. Presentation Date & Speakers: Mar-11-2013, David Thomas, Director, Industry Research and Analysis, Joseph Damond, Senior VP, International Affairs.